eMedicine Specialties > Urology > Infections and Related Inflammatory Conditions

Xanthogranulomatous Pyelonephritis: Treatment

Author: Joe D Mobley III, MD, MPH, Resident Physician, Department of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine/University of Tennessee Medical Center
Coauthor(s): Scott Rutchik, MD, Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine
Contributor Information and Disclosures

Updated: Jun 11, 2008

Treatment

Medical Therapy

Medical therapy has proven sufficient for treatment of xanthogranulomatous pyelonephritis (XGP) in only a handful of cases. Antibiotics may be appropriate as a temporizing measure in patients who require a medical workup prior to nephrectomy. Similarly, appropriate antibiotics should be administered prior to operative intervention.

The choice of antibiotic should be geared toward the identity and sensitivity of the organism. Proteus organisms and E coli are usually sensitive to various antibiotics, including first-generation cephalosporins and trimethoprim-sulfamethoxazole. Pseudomonas species have a narrower spectrum to which they are sensitive, however, and may require the use of aminoglycosides, third-generation cephalosporins, or fluoroquinolones. In patients who are not septic and who have been evaluated on an outpatient basis, the author's preference is to use an oral antibiotic until surgery, when intravenous antibiotics may be administered. Guidelines have not been established regarding the duration of antibiotic therapy after nephrectomy, but the author usually continues an active oral agent for 1 week.

Surgical Therapy

Nephrectomy is the criterion standard of treatment for XGP. These are often challenging cases, particularly in patients with local organ involvement. The goal is to remove all involved granulomatous tissue. If this is not accomplished, the remaining infected tissue may lead to cutaneous fistulae.

Some authors have advocated a role for partial nephrectomy if the disease is limited and therefore amenable to this operation.7

Laparoscopic nephrectomy is feasible for certain cases of XGP. Small pediatric series of XGP have reported success with the laparoscopic technique. However, Bercowsky et al reported that the technical difficulty and associated complications of the procedure negated any benefits over open nephrectomy.8 The increased use of hand-assisted laparoscopic nephrectomy may allow for an acceptable compromise between technical feasibility and acceptable patient morbidity. The laparoscopic approach may be entertained in all cases, but the patient and the patient's family can expect a conversion rate of nearly 50%.

Preoperative Details

  • Appropriate preoperative imaging studies are essential. This is best accomplished with CT scanning.
  • Administer a bowel preparation and preoperative antibiotics.
  • Surgical consent should include provisions for the possibility of operation on adjacent organs.
  • If the patient is diabetic, establish control of hyperglycemia prior to surgery.
  • Correct any preexisting coagulopathy.

Intraoperative Details

A flank approach through the appropriate intercostal/subcostal subcostal space (often the 11th rib) is desirable to avoid contamination of the peritoneum. Transabdominal subcostal exposure may be unavoidable if adjacent organs are involved with the mass.

The basic principles of nephrectomy apply to the extirpation of renal XGP. If possible, a radical nephrectomy (including Gerota fascia) should be performed, since the mass may still represent a neoplasm. All involved tissue must be removed. Liberal irrigation with antibiotic fluid is performed, and a suction drain is left in place.

Postoperative Details

The immediate postoperative care for patients with XGP is consistent with care that follows standard nephrectomy.

  • Watch for signs of sepsis.
  • Institute aggressive pulmonary toilet.
  • Encourage early ambulation.

Follow-up

Annual imaging of the contralateral urinary tract is important. Aggressively treat all urinary tract infections. If possible, eliminate or control the agent or illness that is predisposing the patient to XGP. Evaluation of lower urinary tract pathology and voiding dysfunction may be important in these patients.

Complications

The urological surgeon should maintain a low threshold to involve a general surgeon in patients with xanthogranulomatous pyelonephritis (XGP). Bleeding should be aggressively controlled. On the left, splenic injury may result; if possible, preservation of the spleen should be attempted. Any pancreatic injuries must be identified, repaired, and appropriately drained.

Similarly, right-sided injuries may occur to the duodenum and liver. Liver lacerations during nephrectomy are frequently limited to capsular tears, which may be easily controlled with argon-beam coagulation and pressure. Duodenal injuries require repair and nasogastric and cutaneous drainage. The colon is vulnerable to injury on either side. A patient who has received adequate bowel preparation may typically have these colonic injuries primarily repaired.

Vascular injury, especially on the right side, that involves the inferior vena cava can be humbling. The right-sided processes are often very inflamed and stuck, involving the adrenal and gonadal veins, lending them to avulsion and injury. Great care must be taken when dissecting out the right renal hilum. An alternative is to cross-clamp the hilum, transect it, and oversew the entire bundle. This can be planned or used in an emergency.

Postoperative abscess and cutaneous fistulization may occur, often after the drain has been removed and the patient has been discharged from the hospital. Patients typically present with drainage from the wound and fevers. CT scanning and percutaneous drainage should be performed, along with administration of intravenous antibiotics.

More on Xanthogranulomatous Pyelonephritis

Overview: Xanthogranulomatous Pyelonephritis
Workup: Xanthogranulomatous Pyelonephritis
Treatment: Xanthogranulomatous Pyelonephritis
Follow-up: Xanthogranulomatous Pyelonephritis
Multimedia: Xanthogranulomatous Pyelonephritis
References

References

  1. Peréz LM, Thrasher JB, Anderson EE. Successful management of bilateral xanthogranulomatous pyelonephritis by bilateral partial nephrectomy. J Urol. Jan 1993;149(1):100-2. [Medline].

  2. Tiguert R, Gheiler EL, Yousif R, Tefilli MV, Mills K, Grignon DJ, et al. Focal xanthogranulomatous pyelonephritis presenting as a renal tumor with vena caval thrombus. J Urol. Jul 1998;160(1):117-8. [Medline].

  3. Shah HN, Jain P, Chibber PJ. Renal tuberculosis simulating xanthogranulomatous pyelonephritis with contagious hepatic involvement. Int J Urol. Jan 2006;13(1):67-8. [Medline].

  4. Hitti W, Drachenberg C, Cooper M, Schweitzer E, Cangro C, Klassen D, et al. Xanthogranulomatous pyelonephritis in a renal allograft associated with xanthogranulomatous diverticulitis: report of the first case and review of the literature. Nephrol Dial Transplant. Nov 2007;22(11):3344-7. [Medline].

  5. Loffroy R, Guiu B, Varbédian O, Michel F, Sagot P, Cercueil JP. Diffuse xanthogranulomatous pyelonephritis with psoas abscess in a pregnant woman. Can J Urol. Apr 2007;14(2):3507-9. [Medline].

  6. Malek RS, Elder JS. Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol. May 1978;119(5):589-93. [Medline].

  7. Osca JM, Peiro MJ, Rodrigo M, Martinez-Jabaloyas JM, Jimenez-Cruz JF. Focal xanthogranulomatous pyelonephritis: partial nephrectomy as definitive treatment. Eur Urol. 1997;32(3):375-9. [Medline].

  8. Bercowsky E, Shalhav AL, Portis A, Elbahnasy AM, McDougall EM, Clayman RV. Is the laparoscopic approach justified in patients with xanthogranulomatous pyelonephritis?. Urology. Sep 1999;54(3):437-42; discussion 442-3. [Medline].

  9. Borum ML. An unusual case of nephrobronchial and nephrocolonic fistula complicating xanthogranulomatous pyelonephritis. Urology. Sep 1997;50(3):443. [Medline].

  10. Borzi PA, Yeung CK. Selective approach for transperitoneal and extraperitoneal endoscopic nephrectomy in children. J Urol. Feb 2004;171(2 Pt 1):814-6; discussion 816. [Medline].

  11. Bottalico T, Parks S, Zaslau S, Tarry WF. Pediatric xanthogranulomatous pyelonephritis masquerading as complex renal mass. Urology. Aug 2007;70(2):372.e11-2. [Medline].

  12. Eastham J, Ahlering T, Skinner E. Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations. Urology. Mar 1994;43(3):295-9. [Medline].

  13. Loffroy R, Guiu B, Watfa J, Michel F, Cercueil JP, Krause D. Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clin Radiol. Sep 2007;62(9):884-90. [Medline].

  14. Marteinsson VT, Due J, Aagenaes I. Focal xanthogranulomatous pyelonephritis presenting as renal tumour in children. Case report with a review of the literature. Scand J Urol Nephrol. Jun 1996;30(3):235-9. [Medline].

  15. Matthews GJ, McLorie GA, Churchill BA, Steckler RE, Khoury AE. Xanthogranulomatous pyelonephritis in pediatric patients. J Urol. Jun 1995;153(6):1958-9. [Medline].

  16. Nataluk EA, McCullough DL, Scharling EO. Xanthogranulomatous pyelonephritis, the gatekeeper's dilemma: a contemporary look at an old problem. Urology. Mar 1995;45(3):377-80. [Medline].

  17. Papadopoulos I, Wirth B, Wand H. Xanthogranulomatous pyelonephritis associated with renal cell carcinoma. Report on two cases and review of the literature. Eur Urol. 1990;18(1):74-6. [Medline].

  18. Tan YH, Siddiqui K, Preminger GM, Albala DM. Hand-assisted laparoscopic nephrectomy for inflammatory renal conditions. J Endourol. Oct 2004;18(8):770-4. [Medline].

  19. Toprak U, Erdogan A, Gulbay M, Karademir MA, Pasaoglu E, Akar OE. Preoperative evaluation of renal anatomy and renal masses with helical CT, 3D-CT and 3D-CT angiography. Diagn Interv Radiol. Mar 2005;11(1):35-40. [Medline].

  20. Tunc L, Biri H, Onaran M, Krac M, Yesil S, Bozkirli I. Laparoscopic nephrectomy for xanthogranulomatous pyelonephritis in the absence of kidney stones or clinical urinary infection. Surg Laparosc Endosc Percutan Tech. Dec 2007;17(6):570-2. [Medline].

Further Reading

Keywords

xanthogranulomatous pyelonephritis, XGP, infectious renal phlegmon, long-term renal obstruction, renal cell carcinoma, nephrectomy, pyelocutaneous fistulae, ureterocutaneous fistulae, pyeloenteric fistulae

Contributor Information and Disclosures

Author

Joe D Mobley III, MD, MPH, Resident Physician, Department of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine/University of Tennessee Medical Center
Joe D Mobley III, MD, MPH is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Endourological Society, and Tennessee Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Scott Rutchik, MD, Assistant Professor, Department of Surgery, Division of Urology, University of Connecticut School of Medicine
Scott Rutchik, MD is a member of the following medical societies: American Urological Association
Disclosure: Nothing to disclose.

Medical Editor

Gamal Mostafa Ghoniem, MD, FACS, Fellowship Program Director, Clinical Professor of Surgery, Head, Section of Voiding Dysfunction, Female Urology and Reconstruction, Cleveland Clinic Florida
Gamal Mostafa Ghoniem, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Society for Urology and Engineering, and Society of University Urologists
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

J Stuart Wolf, Jr, MD, FACS, David A Bloom Professor of Urology, Director, Division of Minimally Invasive Urology, Department of Urology, University of Michigan Medical Center
J Stuart Wolf, Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Terumo Corporation Consulting fee Consulting; Omeros Corporation Consulting fee Consulting

Chief Editor

Bradley Fields Schwartz, DO, FACS, Associate Professor of Urology, Director, Center for Laparoscopy and Endourology, Department of Surgery, Southern Illinois University School of Medicine
Bradley Fields Schwartz, DO, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Association of Military Osteopathic Physicians and Surgeons, Endourological Society, Society of Laparoendoscopic Surgeons, and Society of University Urologists
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.